Skip to main content

GLP-1 Receptor Agonists for Type 2 Diabetes Study Guide

This guide provides essential information on the pathophysiology, diagnosis, and management of diabetes mellitus and metabolic syndrome. It covers various types of diabetes, acute and chronic complications, and the pharmacology of treatment options, including insulin and oral medications. Additionally, it details strategies for managing blood glucose levels, preventing complications, and promoting overall health for individuals with diabetes.

Save this study guide to your study set

Sign up free

Your learning path

Diabetes Mellitus Pathophysiology, Management, and Complications

Pathophysiology and Treatment of DKA and HHNS

Comparison of Type 1 and HHNS, including their pathophysiology, diagnostic findings, and priority treatments such as insulin administration and fluid resuscitation.

  • Type 1 Diabetes Pathophysiology
  • Type 2 Diabetes Pathophysiology
  • Diabetic Ketoacidosis (DKA)
  • Hyperglycemic Hyperosmolar Nonketotic Syndrome (HHNS)
  • Kussmaul respirations
  • Metabolic Acidosis
  • Insulin administration
  • Fluid resuscitation
  • Blood glucose monitoring

Diabetes Mellitus Pathophysiology, Treatments, and Education

Management of Type 1 and Type 2 diabetes including pathophysiology, diagnostic labs, insulin types, oral hypoglycemics, hypoglycemia/hyperglycemia, diet, and diabetic foot care.

  • Metabolic Syndrome
  • Type 1 Diabetes Mellitus
  • Type 2 Diabetes Mellitus
  • Hyperglycemia
  • Hypoglycemia
  • Insulin administration
  • Oral hypoglycemics
  • Diabetic complications
  • Diabetic foot care
  • Metformin

Diabetes Management and Metabolic Complications

This content covers diabetes pharmacology, management of DKA and HHS, perioperative glucose targets, and complications including microvascular, macrovascular, and neuropathy.

  • Alpha-glucosidase inhibitors
  • Meglitinides
  • GLP-1 receptor agonists
  • Diabetic Ketoacidosis (DKA)
  • Hyperglycemic Hyperosmolar State (HHS)
  • Macrovascular complications
  • Microvascular complications
  • Sensory and autonomic neuropathy
  • Gestational diabetes

Diabetes Mellitus Pathophysiology and Management

This clinical blueprint covers diabetes mellitus pathophysiology, acute crises including DKA and HHNS, pharmacological management, and perioperative care.

  • Type 1 Diabetes Mellitus
  • Type 2 Diabetes Mellitus
  • Insulin resistance
  • Hypoglycemia symptoms and triggers
  • Hyperglycemia symptoms and triggers
  • Diabetic Ketoacidosis (DKA)
  • Hyperosmolar Hyperglycemic Nonketotic Syndrome (HHNS)
  • Metabolic Acidosis
  • Insulin administration

Diabetes Mellitus Complications and Management

Clinical overview of systemic chronic complications, diabetic foot pathology, risk stratification, and gestational diabetes risks.

  • Macrovascular complications
  • Microvascular complications
  • Neuropathy
  • Diabetic foot pathology
  • Foot risk stratification
  • Gestational diabetes
  • Maternal complications

Gestational Diabetes Management and Complications

Impaired blood glucose regulation during pregnancy involves insulin resistance, nutritional counseling, and monitoring for maternal and newborn complications.

  • Gestational diabetes
  • Insulin resistance
  • Nutritional counseling
  • Glucose Challenge Test
  • Hyperglycemia
  • Hypoglycemia
  • Newborn hypoglycemia
  • Maternal preeclampsia

Diabetes Mellitus and Metabolic Management

GLP-1 Receptor Agonists for Type 2 Diabetes

GLP-1 receptor agonists mimic naturally produced incretin hormones to enhance glucose-dependent insulin secretion and suppress glucagon secretion in patients with Type 2 diabetes, offering potential cardiovascular benefits.

  • GLP-1 receptor agonists
  • Mechanism of action
  • Incretin mimetics
  • Glucose-dependent insulin secretion
  • Glucagon secretion suppression
  • Gastric emptying
  • Type 2 diabetes indications
  • Cardiovascular benefits

Principles of Metabolism and Diabetes Management

This topic covers the pathophysiology and management of type 1 and type 2 diabetes, focusing on insulin resistance, metabolic syndrome, and the role of medications like Metformin.

  • Metabolism definition
  • Type 1 diabetes
  • Type 2 diabetes
  • Insulin resistance
  • Metformin
  • Hypoglycemia
  • Diabetic ketoacidosis (DKA)
  • Metabolic syndrome

Diabetes Mellitus and Metabolic Syndrome Management

Management of Type 1, Type 2, and gestational diabetes including metabolic syndrome markers, diabetic ketoacidosis, hyperosmolar hyperglycemic state, and pharmacology of insulin, glucagon, and metformin.

  • Type 1 Diabetes Mellitus
  • Type 2 Diabetes Mellitus
  • Gestational Diabetes
  • Diabetic Ketoacidosis (DKA)
  • Hyperosmolar Hyperglycemic State (HHS)
  • Insulin therapy
  • Metformin
  • Hypoglycemia management
  • Hyperglycemia complications
  • Metabolic syndrome lipid and blood sugar markers

Diabetes Metabolism and Pharmacological Management

This content covers glucose and glucagon metabolism alongside the mechanisms, administration, adverse effects, and contraindications of various diabetes medications.

  • Thiazolidinediones
  • Insulin sensitizers
  • Sulfonylureas
  • DPP4 inhibitors
  • Alpha glucosidase inhibitors
  • Meglitinides
  • Hypoglycemia risk
  • Mechanism of action
  • Contraindications
  • Adverse effects
  • Type 2 diabetes management
  • Metformin uses, adverse effects, and lactic acidosis risk

Diabetes Mellitus Clinical Management Blueprint

A clinical guide covering insulin pharmacokinetics, oral antidiabetics, patient education, and multisystem complications of diabetes.

  • Insulin pharmacokinetics
  • Rapid, regular, intermediate, and long-acting insulin
  • Metformin and lactic acidosis risk
  • Hypoglycemia Rule of 15
  • Dietary management
  • Sick day rules
  • Fluid and electrolyte management
  • Vascular perfusion and microvessel protection
  • Neurological integrity and autonomic function

Make it your own.

Keep these readings and topics in a new study set, or add them to one you already use.